329 related articles for article (PubMed ID: 31607698)
21. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
Salem ME; Bodor JN; Puccini A; Xiu J; Goldberg RM; Grothey A; Korn WM; Shields AF; Worrilow WM; Kim ES; Lenz HJ; Marshall JL; Hall MJ
Int J Cancer; 2020 Nov; 147(10):2948-2956. PubMed ID: 32449172
[TBL] [Abstract][Full Text] [Related]
22. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.
Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT
Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
[TBL] [Abstract][Full Text] [Related]
24. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC
Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
26. Sporadic Early Onset Colorectal Cancer in Pakistan: a Case- Control Analysis of Microsatellite Instability.
Siddique S; Tariq K; Rafiq S; Raheem A; Ahmed R; Shabbir-Moosajee M; Ghias K
Asian Pac J Cancer Prev; 2016; 17(5):2587-92. PubMed ID: 27268635
[TBL] [Abstract][Full Text] [Related]
27. Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications.
Doghri R; Houcine Y; Boujelbène N; Driss M; Charfi L; Abbes I; Mrad K; Sellami R
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):678-682. PubMed ID: 31567138
[TBL] [Abstract][Full Text] [Related]
28. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time?
Søreide K
Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726
[TBL] [Abstract][Full Text] [Related]
29. Mismatch repair status in sporadic colorectal cancer: immunohistochemistry and microsatellite instability analyses.
Yoon YS; Yu CS; Kim TW; Kim JH; Jang SJ; Cho DH; Roh SA; Kim JC
J Gastroenterol Hepatol; 2011 Dec; 26(12):1733-9. PubMed ID: 21615788
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical Analysis of Mismatch Repair Gene Proteins in Early Gastric Cancer Based on Microsatellite Status.
Sugimoto R; Endo M; Osakabe M; Toya Y; Yanagawa N; Matsumoto T; Sugai T
Digestion; 2021; 102(5):691-700. PubMed ID: 33053554
[TBL] [Abstract][Full Text] [Related]
31. Evidence for an age-related influence of microsatellite instability on colorectal cancer survival.
Farrington SM; McKinley AJ; Carothers AD; Cunningham C; Bubb VJ; Sharp L; Wyllie AH; Dunlop MG
Int J Cancer; 2002 Apr; 98(6):844-50. PubMed ID: 11948461
[TBL] [Abstract][Full Text] [Related]
32. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
33. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comparison Between Mismatch Repair Protein Immunostaining and Microsatellite Instability Testing.
Kim H; Kim HS
Anticancer Res; 2023 Apr; 43(4):1785-1795. PubMed ID: 36974792
[TBL] [Abstract][Full Text] [Related]
34. High homogeneity of mismatch repair deficiency in advanced prostate cancer.
Fraune C; Simon R; Höflmayer D; Möller K; Dum D; Büscheck F; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Hinsch A; Burandt E; Clauditz TS; Wilczak W; Sauter G; Steurer S
Virchows Arch; 2020 May; 476(5):745-752. PubMed ID: 31811435
[TBL] [Abstract][Full Text] [Related]
35. Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study.
Malapelle U; Parente P; Pepe F; De Luca C; Cerino P; Covelli C; Balestrieri M; Russo G; Bonfitto A; Pisapia P; Fiordelisi F; D'Armiento M; Bruzzese D; Loupakis F; Pietrantonio F; Triassi M; Fassan M; Troncone G; Graziano P
Cells; 2020 Sep; 9(9):. PubMed ID: 32887373
[TBL] [Abstract][Full Text] [Related]
36. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic characteristics of resectable colorectal cancer with mismatch repair protein defects in Chinese population: Retrospective case series and literature review.
Li J; Xu Q; Luo C; Chen L; Ying J
Medicine (Baltimore); 2020 Jun; 99(24):e20554. PubMed ID: 32541478
[TBL] [Abstract][Full Text] [Related]
38. Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival.
Kakar S; Aksoy S; Burgart LJ; Smyrk TC
Mod Pathol; 2004 Jun; 17(6):696-700. PubMed ID: 15017435
[TBL] [Abstract][Full Text] [Related]
39. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN
Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458
[TBL] [Abstract][Full Text] [Related]
40. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]